BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21883828)

  • 1. Incidence of second malignancies after external beam radiotherapy for clinical stage I testicular seminoma.
    Lewinshtein D; Gulati R; Nelson PS; Porter CR
    BJU Int; 2012 Mar; 109(5):706-12. PubMed ID: 21883828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary malignancy among seminoma patients treated with adjuvant radiation therapy.
    Chao CK; Lai PP; Michalski JM; Perez CA
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):831-5. PubMed ID: 7591890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations.
    Brown AP; Neeley ES; Werner T; Soisson AP; Burt RW; Gaffney DK
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):127-35. PubMed ID: 19910129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second primary cancer in irradiated stage I testicular seminoma.
    Stein ME; Steiner M; Lachter J; Kessel I; Moskovitz B; Kuten A
    Strahlenther Onkol; 1993 Nov; 169(11):672-7. PubMed ID: 8248844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic follow-up in testicular seminoma patients exposed to adjuvant radiotherapy.
    Gamulin M; Kopjar N; Grgić M; Ramić S; Viculin T; Petković M; Garaj-Vrhovac V
    Coll Antropol; 2010 Jun; 34(2):455-65. PubMed ID: 20698117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality after cure of testicular seminoma.
    Zagars GK; Ballo MT; Lee AK; Strom SS
    J Clin Oncol; 2004 Feb; 22(4):640-7. PubMed ID: 14726503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of postorchiectomy radiation therapy for stage I and II testicular seminoma.
    Akimoto T; Takahashi I; Takahashi M; Yamakawa M; Hayakawa K; Mitsuhashi N; Niibe H
    Anticancer Res; 1997; 17(5B):3781-5. PubMed ID: 9427780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late gastrointestinal morbidity in patients with stage I-II testicular seminoma treated with radiotherapy.
    Hallemeier CL; Davis BJ; Pisansky TM; Choo R
    Urol Oncol; 2014 May; 32(4):496-500. PubMed ID: 24332645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant radiation therapy for early stage seminoma: proton versus photon planning comparison and modeling of second cancer risk.
    Efstathiou JA; Paly JJ; Lu HM; Athar BS; Moteabbed M; Niemierko A; Adams JA; Bekelman JE; Shipley WU; Zietman AL; Paganetti H
    Radiother Oncol; 2012 Apr; 103(1):12-7. PubMed ID: 22391053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer incidence after localized therapy for prostate cancer.
    Moon K; Stukenborg GJ; Keim J; Theodorescu D
    Cancer; 2006 Sep; 107(5):991-8. PubMed ID: 16878323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to the implementation of surveillance for stage I testicular seminoma.
    Arvold ND; Catalano PJ; Sweeney CJ; Hoffman KE; Nguyen PL; Balboni TA; Fosså SD; Travis LB; Beard CJ
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):383-9. PubMed ID: 22349043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
    Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
    J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second non-germ cell malignancies in patients treated for stage I-II testicular seminoma.
    Bachaud JM; Berthier F; Soulié M; Malavaud B; Plante P; Rischmann P; Chevreau C; Daly-Schveitzer N; Grosclaude P
    Radiother Oncol; 1999 Feb; 50(2):191-7. PubMed ID: 10368043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicted rates of secondary malignancies from proton versus photon radiation therapy for stage I seminoma.
    Simone CB; Kramer K; O'Meara WP; Bekelman JE; Belard A; McDonough J; O'Connell J
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):242-9. PubMed ID: 21236595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral testicular germ cell tumors: twenty-year experience at M. D. Anderson Cancer Center.
    Che M; Tamboli P; Ro JY; Park DS; Ro JS; Amato RJ; Ayala AG
    Cancer; 2002 Sep; 95(6):1228-33. PubMed ID: 12216089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer.
    Chrouser K; Leibovich B; Bergstralh E; Zincke H; Blute M
    J Urol; 2005 Jul; 174(1):107-10; discussion 110-1. PubMed ID: 15947588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiotherapy for the treatment of testicular seminomas].
    Sancho Pardo G; Gómez de Segura G
    Arch Esp Urol; 2000; 53(6):505-16. PubMed ID: 11002519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy for stages I and II testicular seminoma: results and morbidity in 238 patients.
    Vallis KA; Howard GC; Duncan W; Cornbleet MA; Kerr GR
    Br J Radiol; 1995 Apr; 68(808):400-5. PubMed ID: 7795977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment-related complications after radiotherapy for testicular malignancies--seminoma stage I and II].
    Golubicić I; Jelić-Radosević Lj; Sobić V
    Srp Arh Celok Lek; 1994; 122(1-2):24-6. PubMed ID: 17972797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.